Mintz Levin Represents Caliper Life Sciences in $600 Million Acquisition by PerkinElmer
BOSTON--([ BUSINESS WIRE ])--[ Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. ] announced that it represented Caliper Life Sciences, Inc. (NASDAQ: CALP), the Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, in its acquisition by PerkinElmer, Inc. (NYSE: PKI) valued at approximately $600 million.
PerkinElmer, Inc. is a Waltham, Massachusetts-based global leader focused on improving the health and safety of people and the environment. The deal will expand PerkinElmeras presence in molecular imaging and detection technologies.
Bank of America Merrill Lynch and Rothschild acted as financial advisors in the deal to PerkinElmer. Perella Weinberg Partners acted as exclusive financial advisor to Caliper Life Sciences and provided a fairness opinion to the Caliper Life Sciences Board of Directors.
Mintz Levin attorneys [ Bill Whelan ], Co-Chair of the Life Sciences Practice Group, and [ Megan Gates ], Co-Chair of the firmas Securities Practice Group, led the transaction with assistance from associates [ Kathleen Tam ], [ Katherine Weir ] and [ Jonathan Urbon ].
For more information on Mintz Levin visit [ www.mintz.com ]